SC 13G

Company

Jasper Therapeutics, Inc.

Filed

January 30, 2023

Accession Number

0001193125-23-019178

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →